Mafalda Sofia Laranjo Cândido


AuthID: R-000-QP9

Confirmed Publications: 186



151
152
TITLE: Halogenated porphyrins as PDT sensitizers, something more than the heavy atom effect?
AUTHORS: Antonio d'A. D R Rocha Gonsalves; Armenio C Serra; Marta Pineiro ; Laranjo, Mafalda ; Ana M Abrantes ; Ana Cristina Gonçalves ; Barbara Oliveiros ; Ana Bela Sarmento ; Maria Filomena Botelho ;
PUBLISHED: 2011, SOURCE: Conference on Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications III in REPORTERS, MARKERS, DYES, NANOPARTICLES, AND MOLECULAR PROBES FOR BIOMEDICAL APPLICATIONS III, VOLUME: 7910
INDEXED IN: WOS CrossRef
IN MY: ORCID | ResearcherID
153
TITLE: 572 MDR modulation in adenocarcinoma cell lines: nuclear medicine as an important approach  Full Text
AUTHORS: Casalta-Lopes, J; A.M Abrantes; Rio, J; Laranjo, Mafalda ; Oliveiros, B; Gonçalves, C; A.B Sarmento-Ribeiro; M.F Botelho;
PUBLISHED: 2010, SOURCE: European Journal of Cancer Supplements, VOLUME: 8, ISSUE: 5
INDEXED IN: CrossRef
IN MY: ORCID
154
155
156
157
158
159
TITLE: In vitro susceptibility of triple negative breast cancer cells to docetaxel, epirubicin and carboplatin  Full Text
AUTHORS: Laranjo, Mafalda ; Carvalho, MJ; Abrantes, AM ; Brito, A; Torgal, I; Oliveira, CF; Maria Filomena Botelho ;
PUBLISHED: 2010, SOURCE: 21st Meeting of the European-Association-for-Cancer-Research in EJC SUPPLEMENTS, VOLUME: 8, ISSUE: 5
INDEXED IN: WOS CrossRef
IN MY: ORCID | ResearcherID
160
TITLE: In vivo metastatic profile of breast cancer cell lines expressing hormonal receptors versus triple negative  Full Text
AUTHORS: Carvalho, M; Abrantes, AM ; Laranjo, Mafalda ; Falcao, F; Cabrita, S; Maria Filomena Botelho ; Oliveira, CF; Torgal, I;
PUBLISHED: 2010, SOURCE: 21st Meeting of the European-Association-for-Cancer-Research in EJC SUPPLEMENTS, VOLUME: 8, ISSUE: 5
INDEXED IN: WOS CrossRef
IN MY: ORCID | ResearcherID
Page 16 of 19. Total results: 186.

footer slogan

Useful Links

Get Help

© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service